Abbott Laboratories ABT
NYSE ABT
$115.17 +0.74 (+0.65%)
At close: Aug 20, 2026 · 12:13 PM UTC

Abbott Laboratories (ABT) Enterprise Value Growth (3y) (2012 - 2026)

Abbott Laboratories (ABT) Enterprise Value Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.38 Bn 18.97 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.51%
Mar 31, 2026 10.59%
Dec 31, 2025 5.88%
Sep 30, 2025 8.53%
Jun 30, 2025 8.17%
Mar 31, 2025 5.97%
Dec 31, 2024 8.31%
Sep 30, 2024 7.27%
Jun 30, 2024 7.15%
Mar 31, 2024 7.64%
Dec 31, 2023 -0.60%
Sep 30, 2023 -14.76%
Jun 30, 2023 -18.05%
Mar 31, 2023 -39.10%
Dec 31, 2022 -36.33%
Sep 30, 2022 -32.88%
Jun 30, 2022 -41.96%
Mar 31, 2022 -37.39%
Dec 31, 2021 -25.88%
Sep 30, 2021 -8.80%